日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

更正：生物制剂在临床实践中的比较有效性和持久性：国际观察性银屑病健康结果研究 (PSoHO) 第 12 个月的结果

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-024-01105-3
Pinter, A; Costanzo, A; Khattri, S; Smith, S D; Carrascosa, J M; Tada, Y; Riedl, E; Reich, A; Brnabic, A; Haustrup, N; Lampropoulou, A; Lipkovich, I; Kadziola, Z; Paul, C; Schuster, C
银屑病
发表日期：2024
文献求助 收藏

Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO

接受PSoHO生物制剂治疗的中重度斑块状银屑病合并指甲银屑病患者的基线特征及mNAPSI评分从基线到第12个月的变化

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-024-01150-y
Riedl, Elisabeth; Pinter, Andreas; Zaheri, Shirin; Costanzo, Antonio; Brnabic, Alan; Konicek, Bruce; McKenzie, Robert; Lampropoulou, Anastasia; Rayes, Mohamed El; Haustrup, Natalie; Schuster, Christopher
银屑病
发表日期：2024
文献求助 收藏

Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

生物制剂在临床实践中的比较疗效和持久性：国际银屑病健康结果观察研究 (PSoHO) 第 12 个月的结果

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-023-01086-9
Pinter, A; Costanzo, A; Khattri, S; Smith, S D; Carrascosa, J M; Tada, Y; Riedl, E; Reich, A; Brnabic, A; Haustrup, N; Lampropoulou, A; Lipkovich, I; Kadziola, Z; Paul, C; Schuster, C
银屑病
发表日期：2024
文献求助 收藏

Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

在银屑病健康结果研究 (PSoHO) 中，确定接受生物制剂治疗的中重度银屑病患者在 12 个月内 PASI100 反应的预测因素

期刊:Acta Dermato-Venereologica
影响因子:3.7
doi:10.2340/actadv.v104.40556
Armstrong, April W; Riedl, Elisabeth; Brunner, Patrick M; Piaserico, Stefano; Visser, Willie I; Haustrup, Natalie; Konicek, Bruce W; Kadziola, Zbigniew; Nunez, Mercedes; Brnabic, Alan; Schuster, Christopher
银屑病
发表日期：2024
文献求助 收藏

Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)

生物制剂治疗中重度银屑病伴特殊部位受累患者的疗效比较：来自观察性银屑病健康结果研究 (PSoHO) 的第 12 周结果

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2023.1185523
Piaserico, Stefano; Riedl, Elisabeth; Pavlovsky, Lev; Vender, Ronald B; Mert, Can; Tangsirisap, Nithi; Haustrup, Natalie; Gallo, Gaia; Schuster, Christopher; Brunner, Patrick M
银屑病
发表日期：2023
文献求助 收藏

The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination

抗SARS-CoV-2单克隆抗体bamlanivimab对COVID-19疫苗的内源性免疫反应影响甚微。

期刊:Science Translational Medicine
影响因子:15.8
doi:10.1126/scitranslmed.abn3041
Robert J Benschop ,Jay L Tuttle ,Lin Zhang ,Josh Poorbaugh ,Nicole L Kallewaard ,Peter Vaillancourt ,Melissa Crisp ,Thi Ngoc Vy Trinh ,Joshua J Freitas ,Stephanie Beasley ,Montanea Daniels ,Natalie Haustrup ,Richard E Higgs ,Ajay Nirula ,Myron S Cohen ,Mary Marovich
SARS-CoV-2
免疫/内分泌
单克隆抗体
发表日期：2022
文献求助 收藏

A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2

对巴姆拉尼维单抗和依特塞维单抗抗体疗法治疗SARS-CoV-2的临床实用性进行叙述性综述

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-021-00515-6
Nathan, Ramesh; Shawa, Imad; De La Torre, Inmaculada; Pustizzi, Jennifer M; Haustrup, Natalie; Patel, Dipak R; Huhn, Gregory
SARS-CoV-2
发表日期：2021
文献求助 收藏

Brain SPECT as an Imaging Biomarker for Evaluating Effects of Novel Treatments in Psychiatry-A Case Series

脑部SPECT作为影像学生物标志物在精神病学新型疗法疗效评估中的应用——病例系列研究

期刊:Frontiers in Psychiatry
影响因子:3.2
doi:10.3389/fpsyt.2021.713141
Best, Steven R D; Haustrup, Natalie; Pavel, Dan G
神经科学
发表日期：2021
文献求助 收藏

Combination therapy with transcranial magnetic stimulation and ketamine for treatment-resistant depression: A long-term retrospective review of clinical use

经颅磁刺激联合氯胺酮治疗难治性抑郁症：一项长期回顾性临床应用研究

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2019.e02187
Best, Steven R D; Pavel, Dan G; Haustrup, Natalie
抑郁症
神经科学
发表日期：2019
文献求助 收藏